Literature DB >> 9294405

Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment.

J P Hammang1, D R Archer, I D Duncan.   

Abstract

Epidermal growth factor (EGF)-responsive stem cells have been identified in the murine central nervous system. These cells can be isolated from the brain and maintained in an undifferentiated state in vitro in the presence of EGF. After removing EGF, the cells cease mitosis and can be induced to differentiate into neurons, astrocytes, and oligodendrocytes. We demonstrate that when the undifferentiated stem cells (nestin-positive) are injected into the myelin-deficient rat spinal cord, they respond to cues within the mutant CNS and differentiate into myelinating oligodendrocytes, in contrast to their behavior in vitro, where they mainly form astrocytes. The cells provide a valuable model system for the study of the development of early oligodendrocytes from multipotent neural stem cells. Because these cells are influenced to divide using growth factors, rather than oncogenes, and because they appear to make appropriate lineage decisions when transplanted into a mutant environment, they may provide an excellent source of cells for a variety of future therapies using cellular transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294405     DOI: 10.1006/exnr.1997.6592

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  27 in total

1.  Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain.

Authors:  R A Fricker; M K Carpenter; C Winkler; C Greco; M A Gates; A Björklund
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

2.  Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus.

Authors:  L S Shihabuddin; P J Horner; J Ray; F H Gage
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 3.  Stem cell transplantation in multiple sclerosis: current status and future prospects.

Authors:  Gianvito Martino; Robin J M Franklin; Anne Baron Van Evercooren; Douglas A Kerr
Journal:  Nat Rev Neurol       Date:  2010-04-20       Impact factor: 42.937

4.  Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord.

Authors:  P J Horner; A E Power; G Kempermann; H G Kuhn; T D Palmer; J Winkler; L J Thal; F H Gage
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 5.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

Review 6.  Prospects for neural stem cell-based therapies for neurological diseases.

Authors:  Jaime Imitola
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

7.  Fate of endogenous stem/progenitor cells following spinal cord injury.

Authors:  Laura L Horky; Francesco Galimi; Fred H Gage; Philip J Horner
Journal:  J Comp Neurol       Date:  2006-10-01       Impact factor: 3.215

Review 8.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

9.  Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord.

Authors:  Michio Inoue; Osamu Honmou; Shinichi Oka; Kiyohiro Houkin; Kazuo Hashi; Jeffery D Kocsis
Journal:  Glia       Date:  2003-11       Impact factor: 7.452

10.  Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIFbeta receptors.

Authors:  R Marmur; J A Kessler; G Zhu; S Gokhan; M F Mehler
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.